Anti-leucine-rich glioma-inactivated 1 encephalitis with manic symptoms as the initial manifestation
Related Experiment Video
Updated: Feb 18, 2026

09:57
Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
3.7K
Tsung-Han Tu1, Yee-Lam E Chan1, Ya-Mei Bai1,2
11 Department of Psychiatry, Taipei Veterans General Hospital, Taipei, Taiwan.
The Australian and New Zealand Journal of Psychiatry
|November 18, 2017
Abstract
No abstract available in PubMed .
Related Concept Videos
Mania and Antimanic Drugs: Overview
666
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
666
Antiepileptic Drugs: Potassium Channel Activators
732
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
732

